Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Biomerica Inc. (NASDAQ: BMRA) closed the day trading at $0.71 down -1.25% from the previous closing price of $0.72. In other words, the price has decreased by -$1.25 from its previous closing price. On the day, 0.66 million shares were traded. BMRA stock price reached its highest trading level at $0.8 during the session, while it also had its lowest trading level at $0.67.
Ratios:
For a better understanding of BMRA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.37 and its Current Ratio is at 4.44. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Colliers Securities on November 10, 2020, initiated with a Buy rating and assigned the stock a target price of $13.
On January 04, 2018, B. Riley FBR Inc. started tracking the stock assigning a Buy rating and target price of $7.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 25 ’23 when Irani Zackary S. bought 200 shares for $1.55 per share. The transaction valued at 310 led to the insider holds 1,020,560 shares of the business.
Irani Zackary S. bought 500 shares of BMRA for $805 on May 24 ’23. The Chief Executive Officer now owns 1,020,360 shares after completing the transaction at $1.61 per share. On May 12 ’23, another insider, Irani Zackary S., who serves as the Chief Executive Officer of the company, bought 1,700 shares for $1.17 each. As a result, the insider paid 1,989 and bolstered with 1,019,860 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMRA now has a Market Capitalization of 12111588 and an Enterprise Value of 7536833. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.22 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 1.394 whereas that against EBITDA is -1.195.
Stock Price History:
Over the past 52 weeks, BMRA has reached a high of $2.13, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -26.88%, while the 200-Day Moving Average is calculated to be -31.41%.
Shares Statistics:
Over the past 3-months, BMRA traded about 57.57K shares per day on average, while over the past 10 days, BMRA traded about 143450 shares per day. A total of 16.82M shares are outstanding, with a floating share count of 15.59M. Insiders hold about 7.30% of the company’s shares, while institutions hold 22.27% stake in the company. Shares short for BMRA as of 1711584000 were 66496 with a Short Ratio of 1.16, compared to 1709164800 on 133454. Therefore, it implies a Short% of Shares Outstanding of 66496 and a Short% of Float of 0.43.
